{
  "table_name": "pharmacogenomics",
  "table_fullname": "open-targets-prod.platform.pharmacogenomics",
  "column_names": [
    "datasourceId",
    "datasourceVersion",
    "datatypeId",
    "directionality",
    "evidenceLevel",
    "genotype",
    "genotypeAnnotationText",
    "genotypeId",
    "haplotypeFromSourceId",
    "haplotypeId",
    "literature",
    "pgxCategory",
    "phenotypeFromSourceId",
    "phenotypeText",
    "studyId",
    "targetFromSourceId",
    "variantFunctionalConsequenceId",
    "variantRsId",
    "isDirectTarget",
    "drugs"
  ],
  "column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "BOOL",
    "STRUCT<list ARRAY<STRUCT<element STRUCT<drugFromSource STRING, drugId STRING>>>>"
  ],
  "nested_column_names": [
    "データソースId",
    "データソースバージョン",
    "データ型Id",
    "方向性",
    "エビデンスレベル",
    "遺伝子型",
    "遺伝子型注釈テキスト",
    "遺伝子型Id",
    "ソース由来ハプロタイプId",
    "ハプロタイプId",
    "文献",
    "文献リスト",
    "文献リスト要素",
    "PGxカテゴリ",
    "ソース由来表現型Id",
    "表現型テキスト",
    "研究Id",
    "ソース由来ターゲットId",
    "変異機能的帰結Id",
    "変異rsId",
    "直接標的か",
    "薬剤",
    "薬剤リスト",
    "薬剤リスト要素",
    "ソース由来薬剤",
    "薬剤Id"
  ],
  "nested_column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "ARRAY<STRUCT<element STRING>>",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "BOOL",
    "STRUCT<list ARRAY<STRUCT<element STRUCT<drugFromSource STRING, drugId STRING>>>>",
    "ARRAY<STRUCT<element STRUCT<drugFromSource STRING, drugId STRING>>>",
    "STRUCT<drugFromSource STRING, drugId STRING>",
    "STRING",
    "STRING"
  ],
  "description": [
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null
  ],
  "sample_rows": [
    {
      "データソースId": "pharmgkb",
      "データソースバージョン": "2024-05-05",
      "データ型Id": "clinical_annotation",
      "方向性": null,
      "エビデンスレベル": "3",
      "遺伝子型": "GG",
      "遺伝子型注釈テキスト": "Patients with the GG genotype may require an increased dose of carbamazepine as compared to patients with the AA genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence dose of carbamazepine.",
      "遺伝子型Id": "1_225838705_A_G,G",
      "ソース由来ハプロタイプId": null,
      "ハプロタイプId": null,
      "文献": {
        "list": "[{'element': '23252947'} {'element': '19620853'} {'element': '22188362'}\n {'element': '15692831'} {'element': '25495409'} {'element': '26555147'}\n {'element': '26555147'}]"
      },
      "PGxカテゴリ": "dosage",
      "ソース由来表現型Id": null,
      "表現型テキスト": "increased dose of carbamazepine",
      "研究Id": "613976757",
      "ソース由来ターゲットId": "ENSG00000143819",
      "変異機能的帰結Id": "SO_0001583",
      "変異rsId": "rs2234922",
      "直接標的か": false,
      "薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "データソースId": "pharmgkb",
      "データソースバージョン": "2024-05-05",
      "データ型Id": "clinical_annotation",
      "方向性": null,
      "エビデンスレベル": "3",
      "遺伝子型": "AG",
      "遺伝子型注釈テキスト": "Patients with the AG genotype may require an increased dose of carbamazepine as compared to patients with the AA genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence dose of carbamazepine.",
      "遺伝子型Id": "1_225838705_A_A,G",
      "ソース由来ハプロタイプId": null,
      "ハプロタイプId": null,
      "文献": {
        "list": "[{'element': '23252947'} {'element': '19620853'} {'element': '22188362'}\n {'element': '15692831'} {'element': '25495409'} {'element': '26555147'}\n {'element': '26555147'}]"
      },
      "PGxカテゴリ": "dosage",
      "ソース由来表現型Id": null,
      "表現型テキスト": "increased dose of carbamazepine",
      "研究Id": "613976757",
      "ソース由来ターゲットId": "ENSG00000143819",
      "変異機能的帰結Id": "SO_0001583",
      "変異rsId": "rs2234922",
      "直接標的か": false,
      "薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "データソースId": "pharmgkb",
      "データソースバージョン": "2024-05-05",
      "データ型Id": "clinical_annotation",
      "方向性": null,
      "エビデンスレベル": "3",
      "遺伝子型": "AA",
      "遺伝子型注釈テキスト": "Patients with the AA genotype may require a decreased dose of carbamazepine as compared to patients with the AG or GG genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence dose of carbamazepine.",
      "遺伝子型Id": "1_225838705_A_A,A",
      "ソース由来ハプロタイプId": null,
      "ハプロタイプId": null,
      "文献": {
        "list": "[{'element': '23252947'} {'element': '19620853'} {'element': '22188362'}\n {'element': '15692831'} {'element': '25495409'} {'element': '26555147'}\n {'element': '26555147'}]"
      },
      "PGxカテゴリ": "dosage",
      "ソース由来表現型Id": null,
      "表現型テキスト": "decreased dose of carbamazepine",
      "研究Id": "613976757",
      "ソース由来ターゲットId": "ENSG00000143819",
      "変異機能的帰結Id": "SO_0002073",
      "変異rsId": "rs2234922",
      "直接標的か": false,
      "薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "データソースId": "pharmgkb",
      "データソースバージョン": "2024-05-05",
      "データ型Id": "clinical_annotation",
      "方向性": null,
      "エビデンスレベル": "3",
      "遺伝子型": "CC",
      "遺伝子型注釈テキスト": "Patients with the CC genotype who are treated with carbamazepine may have an increased risk of Stevens-Johnson syndrome as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for Stevens-Johnson syndrome with carbamazepine treatment.",
      "遺伝子型Id": "6_31639273_C_C,C",
      "ソース由来ハプロタイプId": null,
      "ハプロタイプId": null,
      "文献": {
        "list": "[{'element': '16538176'}]"
      },
      "PGxカテゴリ": "toxicity",
      "ソース由来表現型Id": null,
      "表現型テキスト": "increased risk of Stevens-Johnson syndrome",
      "研究Id": "613976848",
      "ソース由来ターゲットId": "ENSG00000204463",
      "変異機能的帰結Id": "SO_0002073",
      "変異rsId": "rs750332",
      "直接標的か": false,
      "薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "データソースId": "pharmgkb",
      "データソースバージョン": "2024-05-05",
      "データ型Id": "clinical_annotation",
      "方向性": null,
      "エビデンスレベル": "3",
      "遺伝子型": "CT",
      "遺伝子型注釈テキスト": "Patients with the CT genotype who are treated with carbamazepine may have an increased risk of Stevens-Johnson syndrome as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for Stevens-Johnson syndrome with carbamazepine treatment.",
      "遺伝子型Id": "6_31639273_C_C,T",
      "ソース由来ハプロタイプId": null,
      "ハプロタイプId": null,
      "文献": {
        "list": "[{'element': '16538176'}]"
      },
      "PGxカテゴリ": "toxicity",
      "ソース由来表現型Id": null,
      "表現型テキスト": "increased risk of Stevens-Johnson syndrome",
      "研究Id": "613976848",
      "ソース由来ターゲットId": "ENSG00000204463",
      "変異機能的帰結Id": "SO_0001627",
      "変異rsId": "rs750332",
      "直接標的か": false,
      "薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    }
  ]
}